Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Early cancer screening

07.05.2003


A EUREKA funded project is making real progress in the fight against cancer of the large intestine. One of the three most common cancer types in western countries, cancer of the large intestine is also one of the hardest to diagnose. In 50 per cent of cases it is detected too late to be successfully treated with surgery. But EUREKA project GENEFEC has developed a new test which could save thousands of lives by detecting early signs of the disease.

The new DNA-based test, developed by Norwegian company Nordiag and Berlin-based biotechnology firm Invitek GmbH, aims to identify patients with curable pre-cancerous cells in the colon, rectum and pancreas.

“There are a million new cases of colorectal cancer each year, causing around 450,000 deaths,” says Dr Dagfinn Ogreid of the Norsk Center for Gastro-Intestinal Cancerdiagnostikk. “If our test saves just 20% of these patients - and it could be as high as 50% - that’s a lot of lives saved.”



Doctors working in this area have relied upon invasive, time-consuming and painful endoscopic techniques to screen patients. The non-invasive alternative is faecal blood tests, but these tests are not traditionally cancer-specific and have successful detection rates as low as two per cent. Up to 98 per cent of patients are shown to have completely different conditions.

But GENEFEC’s Norwegian and German partners have used a gene which is known to spontaneously mutate in a cell of the gut lining up to five years before the cell becomes malignant, to form the basis of a new and improved faecal test. Nordiag’s Dr Oegreid has developed a method of detecting this mutation using the polymerase chain reaction technique to magnify fragments of DNA shed in the patient’s faeces.

The new test, which takes less than two hours, has attracted interest around the world and is now used by Norway’s public health service. “We have plans to open a laboratory in Berlin with our German partners,” says Dr Ogreid. “This will be an opportunity not only to get into the diagnostic market, but also to work towards our second goal: the robotisation of the tests, which will make the technique even quicker and more reliable.”

The test has enormous market potential. With a population of 4.5 million, Norway has about 4,000 new cases of colorectal cancer every year. There is a market for 20,000 tests a year in Norway alone if doctors screen everyone with a family history of the disease. This figure could rise to over 600,000 if everyone over 40 years old – the highest risk category – is screened. And its impact will of course be widened greatly if it is made available across Europe.

The two partners initially began working on similar technology independently. But when Nordiag scientists became aware that the German group was developing a similar method, it became clear that they could reach their goal faster by pooling their expertise. Dr Oegreid says EUREKA support has been vital to getting the project off the ground. “EUREKA opened doors that allowed us to obtain private sponsorship from insurance companies to fund our research.”

Nicola Vatthauer | alfa
Further information:
http://www.eureka.be/genefec

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>